Opthea

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Opthea and other ETFs, options, and stocks.

About OPT

Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients.

CEO

Frédéric Guerard

CEOFrédéric Guerard

Employees

—

Employees—

Headquarters

South Yarra, Victoria (VIC)

HeadquartersSouth Yarra, Victoria (VIC)

Founded

1984

Founded1984

Employees

—

Employees—

OPT Key Statistics

Market cap

524.84M

Market cap524.84M

Price-Earnings ratio

-1.47

Price-Earnings ratio-1.47

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$6.30

52 Week high$6.30

52 Week low

$1.79

52 Week low$1.79

Analyst ratings

63%

of 8 ratings

Buy

12.5%

Hold

62.5%

Sell

25%